HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A V Schally Selected Research

AN 238

5/2013Anti-tumor effects of peptide analogs targeting neuropeptide hormone receptors on mouse pheochromocytoma cells.
9/2009Expression of neuropeptide hormone receptors in human adrenal tumors and cell lines: antiproliferative effects of peptide analogues.
9/2001Inhibition of the UCI-107 human ovarian carcinoma cell line by a targeted cytotoxic analog of somatostatin, AN-238.
9/2001Targeting of cytotoxic somatostatin analog AN-238 to somatostatin receptor subtypes 5 and/or 3 in experimental pancreatic cancers.
3/2001A targeted cytotoxic somatostatin (SST) analogue, AN-238, inhibits the growth of H-69 small-cell lung carcinoma (SCLC) and H-157 non-SCLC in nude mice.
8/2000Inhibition of growth and metastatic progression of pancreatic carcinoma in hamster after somatostatin receptor subtype 2 (sst2) gene expression and administration of cytotoxic somatostatin analog AN-238.
6/2000Inhibition of metastatic renal cell carcinomas expressing somatostatin receptors by a targeted cytotoxic analogue of somatostatin AN-238.
2/2000Regression of U-87 MG human glioblastomas in nude mice after treatment with a cytotoxic somatostatin analog AN-238.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A V Schally Research Topics

Disease

59Neoplasms (Cancer)
11/2014 - 01/2000
13Carcinoma (Carcinomatosis)
02/2004 - 03/2000
11Prostatic Neoplasms (Prostate Cancer)
11/2014 - 02/2000
11Ovarian Neoplasms (Ovarian Cancer)
08/2012 - 05/2000
8Neoplasm Metastasis (Metastasis)
01/2006 - 06/2000
8Pancreatic Neoplasms (Pancreatic Cancer)
05/2004 - 01/2000
7Breast Neoplasms (Breast Cancer)
06/2008 - 03/2000
6Ovarian Epithelial Carcinoma
05/2001 - 01/2000
4Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
11/2014 - 07/2000
4Glioblastoma (Glioblastoma Multiforme)
10/2010 - 02/2000
4Renal Cell Carcinoma (Grawitz Tumor)
01/2006 - 06/2000
3Carcinogenesis
06/2008 - 05/2000
2Triple Negative Breast Neoplasms
07/2013 - 08/2012
2Pheochromocytoma
05/2013 - 09/2009
2Endometrial Neoplasms (Endometrial Cancer)
08/2012 - 11/2000
2Brain Neoplasms (Brain Tumor)
10/2010 - 02/2000
2Leiomyoma (Uterine Fibroids)
01/2010 - 07/2000
2Endometriosis
01/2010 - 07/2000
2Glioma (Gliomas)
04/2002 - 05/2000
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
03/2001 - 12/2000
2Adenocarcinoma
03/2000 - 02/2000
1Alzheimer Disease (Alzheimer's Disease)
01/2010
1Adrenal Cortex Neoplasms (Adrenocortical Cancer)
09/2009
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2008
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2006
1Melanoma (Melanoma, Malignant)
01/2006

Drug/Important Bio-Agent (IBA)

26Messenger RNA (mRNA)IBA
07/2013 - 01/2000
26Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)IBA
07/2013 - 01/2000
22Gonadotropin-Releasing Hormone (GnRH)FDA Link
05/2013 - 02/2000
20Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
05/2013 - 01/2000
16Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2008 - 03/2000
15Peptides (Polypeptides)IBA
05/2013 - 02/2000
14BombesinIBA
05/2008 - 03/2000
11AN 204 (AN 201)IBA
05/2008 - 02/2000
11Insulin-Like Growth Factor I (IGF-1)IBA
05/2004 - 01/2000
10somatotropin releasing hormone receptorIBA
07/2013 - 09/2000
10Hormones (Hormone)IBA
05/2013 - 02/2000
10Gastrin-Releasing PeptideIBA
06/2005 - 03/2000
9LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA
05/2013 - 02/2000
9Somatostatin Receptors (Somatostatin Receptor)IBA
01/2005 - 01/2000
8AN 238IBA
05/2013 - 02/2000
8Doxorubicin (Adriamycin)FDA LinkGeneric
10/2010 - 02/2000
8Insulin-Like Growth Factor II (Somatomedin A)IBA
05/2004 - 01/2000
7Insulin-Like PeptidesIBA
05/2004 - 01/2000
7JV 1-36IBA
11/2001 - 03/2000
6AndrogensIBA
11/2014 - 07/2000
6cetrorelix (Cetrotide)FDA Link
05/2013 - 05/2000
6lysine(6)-doxorubicin LHRHIBA
05/2013 - 08/2000
6vapreotideIBA
10/2010 - 01/2000
6MZ 5-156IBA
06/2008 - 01/2000
6LigandsIBA
06/2008 - 02/2000
6Estrogens (Estrogen)FDA Link
10/2001 - 02/2000
5Epidermal Growth Factor (EGF)IBA
05/2004 - 03/2000
5JV 1-38IBA
02/2004 - 07/2000
4RNA (Ribonucleic Acid)IBA
06/2008 - 02/2000
4Bombesin Receptors (Bombesin Receptor)IBA
06/2005 - 03/2000
4Tpi(6)-Leu(13)-psi(CH2NH)-Leu(14)- bombesin (6-14)IBA
01/2004 - 03/2000
4Hca(6)-Leu(13)-psi(CH2N)-Tac(14)- bombesin(6-14)IBA
01/2004 - 03/2000
4AN 207IBA
01/2002 - 02/2000
4Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA
11/2001 - 06/2000
4ErbB Receptors (EGF Receptor)IBA
09/2001 - 03/2000
3PhAcTyr(1)- Arg(2)- P(H)e(4- CL)(6)- Ala(8)- Tyr(Me)(10)- His(11)- Abu(15)- His(20)- Nle(27)- Arg(28)- HLCr(29)- GHRH(1-29)NH2IBA
07/2013 - 06/2008
3NeuropeptidesIBA
05/2013 - 07/2000
3Peptide Receptors (Peptide Receptor)IBA
05/2013 - 05/2004
3Proteins (Proteins, Gene)FDA Link
09/2009 - 02/2000
3MZ 4-71IBA
09/2009 - 01/2000
3RC 121IBA
09/2001 - 02/2000
3bombesin receptor subtype 3IBA
11/2000 - 03/2000
3Membrane Proteins (Integral Membrane Proteins)IBA
09/2000 - 02/2000
2Testosterone (Sustanon)FDA Link
11/2014 - 02/2000
2Conditioned Culture MediaIBA
01/2014 - 05/2000
2pentetreotide (OctreoScan)FDA Link
01/2005 - 01/2001
2Cytotoxins (Cytolysins)IBA
01/2005 - 01/2001
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2004 - 09/2001
2AN 215IBA
04/2002 - 11/2000
2Carboxylic Ester HydrolasesIBA
09/2001 - 11/2000
2Radioisotopes (Radionuclides)IBA
10/2000 - 07/2000
1AMP-Activated Protein KinasesIBA
11/2014
1Fatty Acids (Saturated Fatty Acids)IBA
11/2014
1Glucose (Dextrose)FDA LinkGeneric
11/2014
1Adenosine Triphosphate (ATP)IBA
11/2014
1Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaIBA
11/2014
1Phosphotransferases (Kinase)IBA
11/2014
1Docetaxel (Taxotere)FDA Link
07/2013
1somatostatin receptor 2IBA
05/2013
1Har(29)- Arg(28) Nle(27) Orn(21) His(20) Orn(12,) Abu(15) His(11) Tyr(Me)(10) Har(9) Ala(8) Fpa(5,6) Arg(2) (PhAc-Ada)(0)-Tyr(1) GHRH(1-29)NH2IBA
05/2013
1LH Receptors (LH Receptor)IBA
08/2012
1MZ-J-7-118IBA
10/2011
1(N-acetyl-tyr1,D-arg2)fragment 1-29 amideIBA
10/2011
1Nerve Growth Factor (NGF)IBA
09/2009
1Neuropeptide Receptors (Neuropeptide Receptor)IBA
09/2009
1Somatotropin Receptors (Growth Hormone Receptor)IBA
09/2009
1Growth Hormone (Somatotropin)IBA
09/2006

Therapy/Procedure

23Therapeutics
11/2014 - 01/2000
11Drug Therapy (Chemotherapy)
08/2012 - 02/2000
4Injections
03/2001 - 02/2000
3Aftercare (After-Treatment)
11/2000 - 02/2000
2Prostatectomy (Retropubic Prostatectomy)
07/2000 - 02/2000
1Precision Medicine
08/2012
1Subcutaneous Injections
10/2011